Literature DB >> 3097077

Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man.

M Williams, J B Young, R M Rosa, S Gunn, F H Epstein, L Landsberg.   

Abstract

Since dietary protein increases urinary dopamine (DA) excretion in animals, this study was undertaken to assess the role of DA production in the acute changes in renal function following protein ingestion in man. Excretion of DA, sodium, potassium, water, solute, and creatinine were measured in six normal men in 30-min intervals over 5 h after oral ingestion of protein and/or carbidopa, an inhibitor of DA formation from 3,4-dihydroxyphenylalanine (DOPA). Overall, protein increased urinary DA 50% (P = 0.031) while carbidopa reduced it 70% (P less than 0.0001), although suppression of DA excretion by carbidopa was not uniform over the 5 h of observation. Carbidopa doubled the level of DOPA in venous plasma and greatly magnified the DOPA response to protein. Inhibition of decarboxylase activity reduced excretion of sodium, potassium, solute and water after protein ingestion. These results indicate that extraneuronal DOPA decarboxylation in kidney contributes to acute protein-induced changes in renal function in man and suggest a general role for the decarboxylation of circulating DOPA in the expression of dopaminergic effects on the kidney in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097077      PMCID: PMC423943          DOI: 10.1172/JCI112763

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Augmentation of sodium and potassium excretion, glomerular filtration rate and renal plasma flow by levodopa.

Authors:  G D Finlay; T L Whitsett; E A Cucinell; L I Goldberg
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

2.  Phosphaturic effect of dopamine in dogs. Possible role of intrarenally produced dopamine in phosphate regulation.

Authors:  J L Cuche; G R Marchand; R F Greger; R C Lang; F G Knox
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  Dopa decarboxylase: substrates, coenzyme, inhibitors.

Authors:  T L Sourkes
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

4.  The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone?

Authors:  S G Ball; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

5.  Changes in catecholamine excretion after short-term tyrosine ingestion in normally fed human subjects.

Authors:  J C Agharanya; R Alonso; R J Wurtman
Journal:  Am J Clin Nutr       Date:  1981-01       Impact factor: 7.045

6.  Effects of tyrosine infusion in normotensive and hypertensive rats.

Authors:  M R Bresnahan; P Hatzinikolaou; H R Brunner; H Gavras
Journal:  Am J Physiol       Date:  1980-08

7.  Tubular secretion and metabolism of dopamine, norepinephrine, methoxytyramine and normetanephrine by the rat kidney.

Authors:  A D Baines; A Craan; W Chan; N Morgunov
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

8.  Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.

Authors:  C Hansson; G Agrup; H Rorsman; E Rosengren
Journal:  Acta Derm Venereol       Date:  1980       Impact factor: 4.437

9.  Dopaminergic regulation of natriuretic response to acute volume expansion in dogs.

Authors:  M McClanahan; J R Sowers; F W Beck; P K Mohanty; T McKenzie
Journal:  Clin Sci (Lond)       Date:  1985-03       Impact factor: 6.124

10.  Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man.

Authors:  R W Alexander; J R Gill; H Yamabe; W Lovenberg; H R Keiser
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  8 in total

1.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

2.  β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis.

Authors:  Sergio E Chiarella; Saul Soberanes; Daniela Urich; Luisa Morales-Nebreda; Recep Nigdelioglu; David Green; James B Young; Angel Gonzalez; Carmen Rosario; Alexander V Misharin; Andrew J Ghio; Richard G Wunderink; Helen K Donnelly; Kathryn A Radigan; Harris Perlman; Navdeep S Chandel; G R Scott Budinger; Gökhan M Mutlu
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

3.  Chronobiology of catecholamine excretion in normal and diabetic men.

Authors:  G Del Rio; C Carani; A Baldini; P Marrama; L Della Casa
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

4.  Dopamine D2-like receptors and amino acid-induced glomerular hyperfiltration in humans.

Authors:  G Luippold; S Schneider; A Stefanescu; P Benöhr; B Mühlbauer
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

5.  Renal response to amino acid infusion in rats: effect of dopamine receptor antagonists and benserazide.

Authors:  B Mühlbauer; E Hartenburg; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

6.  Inability to demonstrate physiologic correlates of subjective improvement among patients taught the relaxation response.

Authors:  D M Eisenberg; L Landsberg; E N Allred; R B Saper; T L Delbanco
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

7.  Urinary Dopamine Excretion Rate Decreases during Acute Dietary Protein Deprivation and Is Associated with Increased Plasma Pancreatic Polypeptide Concentration.

Authors:  Alessio Basolo; Tim Hollstein; Mary Walter; Jonathan Krakoff; Paolo Piaggi
Journal:  Nutrients       Date:  2021-04-08       Impact factor: 5.717

8.  Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population.

Authors:  George J Trachte; Thomas Uncini; Marty Hinz
Journal:  Neuropsychiatr Dis Treat       Date:  2009-05-20       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.